Future Oncology Study: Augmented Intelligence to Predict 30-day Mortality in Patients with Cancer
With more than 1.6 million Americans diagnosed with cancer each year, oncology providers are turning to AI-powered prescriptive insights to deliver better care.
In a recent study published by Future Oncology, Cardinal Health Speciality Solutions, Jvion and Northwest Medical Specialties report that Jvion’s clinical AI accurately predicts short-term mortality risk among patients with cancer and guides the appropriate use of interventions and palliative care services.
- By 2023, 2.3 million people will be newly diagnosed with cancer in the U.S.1
- By 2030, the number of cancer survivors is projected to increase by 31.4%, to 22.2 million2
1 IOM (Institute of Medicine). 2013. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: The National Academies Press.
2 National Cancer Institute Division of Cancer Control & Population Sciences. 2020.